ArticleGenes2022

Germline Testing in a Cohort of Patients at High Risk of Hereditary Cancer Predisposition Syndromes: First Two-Year Results from South Italy.

Francesco Paduano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.